ALDX
Aldeyra Therapeutics, Inc.
0.93$
-1.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | -0.65 | -0.36 | -1.24 | -1.08 | -1.33 | -1.21 | -1.38 | -1.66 | -1.10 | -0.79 | -0.97 | -0.51 | -0.73 | -0.56 | |
| 0.00 | 0.00 | – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.01 | 0.07 | 0.35 | 0.53 | 0.25 | 0.24 | 0.17 | 0.19 | 0.30 | 0.21 | 0.13 | 0.14 | 0.10 | 0.13 | 0.10 | |
| – | – | – | 0.53 | 0.25 | 0.24 | 0.17 | 0.19 | 0.49 | 0.25 | 0.13 | 0.14 | – | – | – | |
| -0.01 | 0.08 | 0.05 | 0.14 | 0.06 | 0.04 | 0.01 | 0.23 | 0.10 | -0.26 | 0.14 | -0.06 | 0.01 | 0.10 | -0.09 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | 0.00 | -1.51 | -0.02 | -0.64 | -1.08 | 0.68 | 0.85 | 0.00 | -0.51 | 0.51 | -0.76 | 0.79 | |
| – | – | – | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| – | – | – | 2.61 | 3.30 | 1.12 | 2.36 | 3.78 | 0.34 | 1.23 | 3.60 | 0.02 | -0.01 | – | – | |
| – | – | – | – | -0.16 | -0.12 | -0.09 | -0.06 | 0.53 | – | – | 0.00 | -0.02 | 0.00 | 0.00 | |
| – | 1.46 | 0.78 | 2.61 | 3.30 | 1.12 | 2.35 | 3.71 | 0.87 | 1.23 | 3.60 | 0.02 | -0.02 | 0.00 | 0.02 | |
| -0.50 | 0.81 | 0.42 | 1.37 | 0.71 | -0.23 | 0.50 | 1.26 | -0.11 | 0.98 | 2.81 | -1.46 | -0.03 | -1.48 | 0.26 | |
| -0.50 | -0.65 | -0.36 | -1.24 | -1.09 | -1.34 | -1.21 | -1.39 | -1.66 | -1.10 | -0.79 | -0.97 | -0.51 | -0.73 | -0.56 |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.